Researchers Identify New Target for Developing Flavivirus Vaccines

Digital media& downloads
Researchers Identify New Target for Developing Flavivirus Vaccines
Antibodies normally fight viruses, but in the case of flaviviruses, they can make infections worse. UArizona Health Sciences immunologists took a closer look at antibody production to figure out why, which could lead to new methods of developing vaccines for flaviviruses.  
Stacy Pigott
Today
University CommunicationsDeepta_DSC8329-web.jpg
Deepta Bhattacharya works in his laboratory at the University of Arizona Health Sciences. Findings from Bhattacharya's recent research of flaviviruses give him and his team a new way to think about vaccines for the types of viruses that cause diseases such as dengue, yellow fever, West Nile and Zika.
Noelle Haro-Gomez/University of Arizona Health SciencesHealthScience and TechnologyBIO5College of Medicine - TucsonResearcher contact:Deepta Bhattacharya
[e-mail] contact:Stacy Pigott
[e-mail] results of a recent study moved  University of Arizona Health Sciences researchers one step closer to developing effective vaccinations against flaviviruses, which infect more than 400 million people a year with diseases such as dengue, yellow fever, West Nile, Zika and Japanese encephalitis.When a person is infected with a virus, antibodies are produced to fight the virus and provide immunity against reinfection. In the case of flaviviruses, however, if a person gets a second flavivirus...

Source: The University of Arizona: Health - October 2, 2020 Category: Universities & Medical Training Authors: mittank Source Type: research